BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30028443)

  • 41. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
    Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
    J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of positron emission tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating between malignant and benign intraductal papillary mucinous neoplasms (IPMNs).
    Ohta K; Tanada M; Sugawara Y; Teramoto N; Iguchi H
    Pancreatology; 2017; 17(6):911-919. PubMed ID: 29033011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
    Roch AM; Barron MR; Tann M; Sandrasegar K; Hannaford KN; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2015 Jul; 221(1):48-56. PubMed ID: 26095551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicentric invasive carcinomas derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas: report of a case.
    Naitoh Y; Ban S; Tsuchiya C; Sugiura Y; Shimizu M
    Virchows Arch; 2007 Apr; 450(4):487-90. PubMed ID: 17333261
    [No Abstract]   [Full Text] [Related]  

  • 45. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.
    Ikegawa T; Masuda A; Sakai A; Toyama H; Zen Y; Sofue K; Nakagawa T; Shiomi H; Takenaka M; Kobayashi T; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Azuma T
    Pancreatology; 2018 Jun; 18(4):399-406. PubMed ID: 29685673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Extrapancreatic tumors in intraductal papillary mucinous neoplasm of the pancreas].
    Oh SJ; Lee SJ; Lee HY; Paik YH; Lee DK; Lee KS; Chung JB; Yu JS; Yoon DS
    Korean J Gastroenterol; 2009 Sep; 54(3):162-6. PubMed ID: 19844152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
    J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.
    Dal Molin M; Hong SM; Hebbar S; Sharma R; Scrimieri F; de Wilde RF; Mayo SC; Goggins M; Wolfgang CL; Schulick RD; Lin MT; Eshleman JR; Hruban RH; Maitra A; Matthaei H
    Hum Pathol; 2012 Apr; 43(4):585-91. PubMed ID: 21940037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms.
    Pitman MB; Centeno BA; Daglilar ES; Brugge WR; Mino-Kenudson M
    Cancer Cytopathol; 2014 Jan; 122(1):40-7. PubMed ID: 23939829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms.
    Permuth JB; Choi J; Balarunathan Y; Kim J; Chen DT; Chen L; Orcutt S; Doepker MP; Gage K; Zhang G; Latifi K; Hoffe S; Jiang K; Coppola D; Centeno BA; Magliocco A; Li Q; Trevino J; Merchant N; Gillies R; Malafa M;
    Oncotarget; 2016 Dec; 7(52):85785-85797. PubMed ID: 27589689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging features of large intraductal papillary mucinous carcinoma of the pancreatic tail.
    Takahashi Y; Sakamoto Y; Shimada K; Sano T; Kosuge T; Onaya H; Mizuguchi Y; Hiraoka N
    Pancreas; 2006 Apr; 32(3):334-5. PubMed ID: 16628093
    [No Abstract]   [Full Text] [Related]  

  • 55. Ultrasonographic characteristics of intraductal papillary mucinous neoplasm of the pancreas.
    Lü K; Dai Q; Xu ZH; Zhang YX; Tan L; Yuan Y; Jiang YX
    Chin Med Sci J; 2010 Sep; 25(3):151-5. PubMed ID: 21180276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dilated common bile duct is commonly associated with main duct Intraductal Papillary Mucinous Neoplasm of the pancreas.
    Sbeit W; Shahin A; Khoury T
    BMC Gastroenterol; 2024 Jun; 24(1):201. PubMed ID: 38886637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
    Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M
    Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraductal papillary mucinous neoplasm of the pancreas: Cytomorphology, imaging, molecular profile, and prognosis.
    Geramizadeh B; Marzban M; Shojazadeh A; Kadivar A; Maleki Z
    Cytopathology; 2021 Jul; 32(4):397-406. PubMed ID: 33792980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
    Raman SP; Kawamoto S; Blackford A; Hruban RH; Lennon AM; Wolfgang CL; Rezaee N; Edil B; Fishman EK
    AJR Am J Roentgenol; 2013 Mar; 200(3):563-9. PubMed ID: 23436845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
    Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.